Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Completed
Dr. Reddy's Laboratories Limited
Phase 1
2007-12-01
The objective of this study was to compare the relative bioavailability of zafirlukast
tablets 20 mg with that of 'ACCOLATE®' tablets 20 mg (zafirlukast tablets 20 mg) in healthy,
adult, human, subjects under fasting conditions and to monitor safety of subjects.
Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial
Terminated
University of California, San Francisco
Phase 2
2017-03-13
A 2 arm, 90 patient (45 per cohort) trial in patients with breast cancer who will be
undergoing mastectomy with immediate tissue-expander reconstruction to determine whether
treatment with zafirlukast (20mg PO BID) can reduce or prevent the development of capsular
contracture.
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Recruiting
National Institutes of Health (NIH)
Phase 2
2020-06-24
This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity
in participants with tumor marker-only relapsed ovarian cancer.
- The name of the study drug involved in this study is:
- Zafirlukast
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Recruiting
Dana-Farber Cancer Institute
Phase 2
2020-06-24
This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity
in participants with tumor marker-only relapsed ovarian cancer.
- The name of the study drug involved in this study is:
- Zafirlukast
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
